Advanced Biomed Inc - ADVB Market Valuation

Graphic logo of Advanced Biomed Inc (ADVB)

The following quotes for Advanced Biomed Inc (ADVB) demonstrate the price action of a biotech company that attracts scientists through its mission-driven approach and long-term premiums for breakthroughs in early tumor detection. Management is focused on validating test efficacy to ensure their inclusion in standard medical protocols, while the market capitalization stands at 0.00. Operational stability is secured via diversified microchip supplies through reliable contracts.

Advanced Biomed - ADVB Market Value (period 03/07/2025 - 11/11/2026)
Product sample of Advanced Biomed

Market capitalization determines the total value of all a company's shares, reflecting investors' current valuation of the business. Analyzing this metric allows for the identification of overvalued assets and protects capital from market volatility. The market value dynamics of the issuer on GURU.Markets demonstrate the market's reaction to the fundamental successes of Advanced Biomed Inc (ADVB). The high precision of biosample logistics for cancer diagnostics directly impacts investment attractiveness, while the efficiency of operational networks ensures the stability of the capitalization.

Competitors of Advanced Biomed Inc (ADVB)

Market Capitalization ONC (BeiGene)|HALO: Market Capitalization|RVMD: Market Valuation|AAPG: Market Value|CGON: Market Capitalization|URGN (urogen.com) - Market Value|BCAX (Bicara Therapeutics) - Market Capitalization|Market Valuation Personalis Inc (PSNL)|Market Capitalization ERAS|Market Capitalization Delcath Corp (DCTH)|Market Value Y-mAbs Therapeutics YMAB|AURA: Market Capitalization|Candel - Market Capitalization|Accuray Inc (ARAY) - Market Valuation|SLS: Market Capitalization|Market Value Actuate Therapeutics Inc (ACTU)|Market Value Citius Oncology, Inc.|HURA: Market Value|Market Valuation TARA (Protara Therapeutics, Inc.)|FATE (Fate Therapeutics Inc) - Market Value|Market Capitalization WHWK (Aadi Bioscience)|TCRX - Market Valuation|CSBR: Market Valuation|XBIT - Market Capitalization|cel-sci.com (CVM) - Market Value|OS Therapies Inc. - Market Value|RADX (Radiopharm Theranostics) - Market Capitalization|Market Value Artiva ARTV|Market Capitalization ANL|Market Capitalization verupharma.com (VERU)|Market Capitalization TPST (Tempest Therapeutics, Inc.)|XLO: Market Capitalization|RENB: Market Valuation|MURA: Market Value|KAPA: Market Capitalization|OnKure Therapeutics (OKUR) - Market Capitalization|Market Value CytoMed Therapeutics Ltd|Market Capitalization CRIS (Curis Corp)|Market Capitalization APLM|Market Valuation Tharimmune Corporation THAR|Market Capitalization GNPX (Genprex, Inc.)|Calidi Biotherapeutics Inc. (CLDI) - Market Value|Sunshine Biopharma - Market Capitalization|XBIO (Xenetic Biosciences) - Market Capitalization|SLRX (Salarius) - Market Valuation|Kitov Pharma - Market Value|AONC (American Oncology Network Inc) - Market Capitalization|Market Value BGNE|Market Capitalization CKPT|Market Capitalization Elevation Oncology Inc.|Market Value iCAD ICAD|Ikena Oncology Inc. (IKNA) - Market Value|NTBL - Market Value|Viracta Therapeutics (VIRX) - Market Valuation|MOR: Market Capitalization|Market Value NAYA Biosciences Inc (NAYA)|AAPGV (Ascentage Pharma Group Ltd) - Market Capitalization